Background The prevalence and severity of duodenal injury in coeliac disease patients controlled on a gluten-free diet is unclear. Aims To use quantitative histology to assess duodenal injury in treated coeliac disease. Methods Quantitative histology in pre-treatment duodenal biopsies collected in clinical trials assessing an investigational immunotherapy for coeliac disease was analysed. Morphometric readings were…
GastroHep Template
Write in a clean editor, then format for GastroHep in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the GastroHep format
GastroHep is a peer-reviewed journal published by Wiley, covering Liver Disease Diagnosis and Treatment, Inflammatory Bowel Disease, Helicobacter pylori-related gastroenterology studies.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." GastroHep 12 (3): 45–58.
Formats any DOI in GastroHep style. No sign-up. |
| Publishes research in | Liver Disease Diagnosis and Treatment Inflammatory Bowel Disease Helicobacter pylori-related gastroenterology studies Liver Disease and Transplantation Gastrointestinal motility and disorders |
| ISSN | 1478-1239 |
| Citation impact (2-yr) | 0.38 |
| h-index | 14 |
| i10-index | 27 |
| Total citations | 791 |
| Open access | Yes |
| Top institutions publishing here | Hull York Medical School |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in GastroHep per year
Citation impact of GastroHep by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in GastroHep
BACKGROUND: Celiac disease (CD) is a widespread autoimmune disease triggered by dietary gluten that can lead to severe gastrointestinal symptoms. Because there is no available treatment other than a lifelong gluten-free diet, many patients continue to experience chronic symptoms. AIM: In this analysis we report on the efficacy of latiglutenase, an orally administered enzyme treatment,…
Background Paediatric onset IBD (pIBD) has been reported to be more aggressive than adult onset IBD (aIBD). Yet, a more extensive disease presentation in paediatric onset ulcerative colitis (pUC) has been the only consistent finding. Aims In a population-based study, we aimed to further elucidate the differences in disease course between pIBD and aIBD. Methods…
BACKGROUND & AIMS: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19), which in males, especially in advanced age, can sometimes evolve into acute respiratory distress syndrome. In addition, mild to moderate alterations in liver function tests (LFTs) have been reported in the worst affected patients. Our review aims to analyse…
Background To quantify the effects of COVID-19 on our inflammatory bowel disease (IBD) unit, including service provision, prescribing practices and use of therapeutic drug monitoring (TDM). Methods We performed a single centre retrospective observational cohort study. Data was extracted from our IBD database, electronic patient records and radiology/endoscopy reporting systems between 16/3/20-17/4/20 and the corresponding…